查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363334

生命科學BPO市場規模、佔有率和趨勢分析報告：按服務、地區和細分市場分類的趨勢，2023-2030年

Life Sciences BPO Market Size, Share & Trends Analysis Report By Services (Pharmaceutical Outsourcing, Medical Devices Outsourcing, Contract Sales And Marketing Outsourcing, Others), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 275 Pages | 商品交期: 2-10個工作天內

價格

生命科學BPO市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球生命科學BPO市場規模預計將達到8,275億美元，預測期內年複合成長率為9.3%。

藥物開發、臨床前研究、臨床試驗和上市後監督成本上升、專利懸崖上升、產品平臺增加和法規限制是推動市場的主要要素。製藥和生物技術產業在研發部門投入大量資金，並不斷推出新的分子、設備和治療方法。藥物藥物研發的各個階段，包括藥物發現、臨床前測試和臨床試驗，都需要大量的資金、技術和人力資源。

外包供應商日益擴大其產品和服務範圍，以滿足行業不斷成長的需求，並瞄準利基領域以實現長期成長和盈利。綜合考慮這些趨勢，生命領域外包市場預計將在預測期內擴大。在 COVID-19大流行期間，許多外包供應商擴大了現有的製造和研究設施，以滿足對 COVID-19 疫苗和診斷不斷成長的需求。大流行後，CDMO 實施類似的策略來支持未來的藥品需求。例如，2022年 4月，Aenova 集團投資 1,000 萬歐元開發一座新設施，用於生產高活性藥物。

預計市場相關人員採取此類策略將對市場有利。人們對降低藥品和醫療設備的製造和開發成本的需求日益成長。外包製造、研究和行銷服務可以為製藥和醫療設備公司節省成本和時間。預計這將對市場產生積極影響。近年來，CRO 和 CDMO 之間的併購有所增加。對臨床服務的需求不斷成長，以及對專業服務提供者提高對核心能力的關注的需求不斷成長，要素將推動併購交易的發生。

生命科學BPO市場報告亮點

  • 併購交易的增加擴大了 CRO 和 CDMO 的全球影響力，並提高了它們提供端到端服務的能力。這種趨勢的持續預計將為市場帶來顯著的好處。
  • 由於全球疫苗接種活動的擴大，COVID-19 的罹患率顯著下降。
  • 因此，CRO 和 CDMO 目前正致力於開發治療高負擔癌症和其他疾病的藥物。
  • 例如，2022年4月，Labcorp將與Xcell Biosciences合作，協助該公司開發細胞和基因療法來治療癌症、帕金森氏症和其他罕見疾病。
  • 鑑於基因療法在治療癌症和其他罕見疾病方面的高效性，CDMO 的此類舉措可能會使市場受益。
  • 由於醫療設備設計的複雜性，預計2023年至2030年醫療設備領域的年複合成長率最快。
  • 全球醫療設備認證法規結構更加嚴格，進一步增加了對醫療設備外包服務的需求。
  • 由於存在大量提供具有成本效益的BPO服務的 CRO，亞太地區在2022年佔據了最大的收入佔有率。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 生命科學BPO市場變數、趨勢與範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 普及和成長預測圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 生命科學BPO市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 生命科學 BPO：依服務進行估算和趨勢分析

  • 生命科學BPO市場：重點
  • 生命科學BPO市場：2022年和2030年趨勢和市場佔有率分析
  • 醫藥外包
    • 合約製造市場
    • 受託研究機構
  • 醫療設備外包
    • 合約製造外包
    • 受託研究機構
  • 合約銷售和市場外包
  • 其他

第5章 生命科學BPO市場：區域估計與趨勢分析

  • 區域預測
  • 依地區分類的生命科學BPO市場：要點
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東、非洲

第6章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Atos SE
    • Boehringer Ingelheim International GmbH
    • Catalent, Inc
    • Labcorp Drug Development
    • Genpact
    • ICON plc
    • Infosys Limited
    • IBM
    • Lonza
    • Parexel
    • IQVIA Inc
Product Code: 978-1-68038-959-3

Life Sciences BPO Market Growth & Trends:

The global life sciences BPO market size is expected to reach USD 827.5 billion by 2030, registering a CAGR of 9.3% over the forecast years, according to a new report by Grand View Research, Inc.. The rising costs of drug development; pre-clinical and clinical trials; and post-marketing surveillance; a rise in the patent cliff; a growing product pipeline; and regulatory constraints are some of the major factors driving the market. The pharmaceutical and biotech industries invest heavily in the R&D sector to continuously introduce new molecules, devices, and treatments. The different stages of drug development, such as drug discovery, pre-clinical studies, and clinical trials, require huge financial, technological, and human resources.

To cater to the growing needs of the industry, the outsourcing vendors are expanding their product and service offerings and they are targeting niche areas for long-term growth and profitability. Altogether, these trends are expected to boost the life sciences outsourcing market over the forecast period. During the COVID-19 pandemic, a significant number of outsourcing providers expanded their existing manufacturing and research facilities to meet the growing demand for COVID-19 vaccines and diagnostics. Even post-pandemic, CDMOs are practicing similar strategies to support the future demand for pharmaceuticals. For instance, in April 2022, Aenova Group developed a new facility for manufacturing highly potent drugs with an investment of EUR 10 million.

The adoption of such strategies by the market players is expected to be profitable for the market. There has been a rising demand to reduce the cost of manufacturing and development of drugs and medical devices. Outsourcing manufacturing, research, and marketing services provide pharmaceutical and medical device companies with cost- and time-saving benefits. This is expected to have a positive impact on the market. Over the years, mergers and acquisition deals between CROs and CDMOs have increased. The rising demand for clinical services and the growing need for specialized service providers to improve the focus on their core competencies are some of the factors that are expected to drive the incidence of M&A deals.

Life Sciences BPOMarket Report Highlights:

  • The increasing number of M&A transactions has broadened the global reach and improved the capabilities of CROs and CDMOs to provide end-to-end services; a continuation of this trend is expected to benefit the market significantly
  • COVID-19 incidence has decreased significantly as a result of a growing global vaccination campaign
  • Owing to this, the CRO and CDMO are now refocusing on developing drugs for oncology and other diseases owing to their high burden
  • For instance, in April 2022, Labcorp collaborated with Xcell Biosciences to support the company in developing cell and gene therapies for treating cancer, Parkinson's, and other rare diseases
  • Such initiatives by the CDMOs are likely to profit the market owing to the high effectiveness of gene therapy in treating cancer and other rare diseases
  • The medical device segment is expected to register the fastest CAGR from 2023 to 2030 due to the complexities associated with medical device designing
  • The strict regulatory framework for medical device approval globally has further contributed to the demand for medical device outsourcing services
  • Asia Pacific held the largest revenue share in 2022 due to the presence of a significant number of CROs providing cost-effective BPO services

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Services
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Services outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Life Sciences BPO Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Life Sciences BPO Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic Landscape

Chapter 4. Life Sciences BPO: Service Estimates & Trend Analysis

  • 4.1. Life Sciences BPO Market: Key Takeaways
  • 4.2. Life Sciences BPO Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Pharmaceutical Outsourcing
    • 4.3.1. Pharmaceutical outsourcing market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.3.2. Contract manufacturing market
      • 4.3.2.1. Contract manufacturing market estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.2.2. API
      • 4.3.2.2.1. API estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.2.3. Finished dose form
      • 4.3.2.3.1. Finished dose form estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.2.4. Packaging
      • 4.3.2.4.1. Packaging estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.3.3. Contract research organizations
      • 4.3.3.1. Contract research Organizations estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.3.2. Drug discovery
      • 4.3.3.2.1. Drug discovery estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.3.3. Preclinical studies
      • 4.3.3.3.1. Preclinical studies estimate and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.3.4. Clinical Trial Studies
      • 4.3.3.4.1. Clinical trial studies estimate and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.3.5. Regulatory services
      • 4.3.3.5.1. Regulatory services estimate and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.3.6. Pharmacovigilance
      • 4.3.3.6.1. Pharmacovigilance estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.4. Medical Devices Outsourcing
    • 4.4.1. Medical devices outsourcing market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.4.2. Contract manufacturing outsourcing
      • 4.4.2.1. Contract manufacturing outsourcing estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.4.2.2. Electronic manufacturing services
      • 4.4.2.2.1. Electronic manufacturing services estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.4.2.3. Finished goods
      • 4.4.2.3.1. Finished goods estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.4.2.4. Raw materials/components
      • 4.4.2.4.1. Raw materials/components estimate and forecasts, 2018 to 2030 (USD Billion)
    • 4.4.3. Contract research organizations
      • 4.4.3.1. Contract research Organizations estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.4.3.2. Regulatory consulting services
      • 4.4.3.2.1. Regulatory consulting services estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.4.3.3. Product design and development services
      • 4.4.3.3.1. Product design and development services estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.4.3.4. Product testing services
      • 4.4.3.4.1. Product testing services estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.4.3.5. Product implementation services
      • 4.4.3.5.1. Product implementation services estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.4.3.6. Product upgrade services
      • 4.4.3.6.1. Product upgrade services estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.4.3.7. Product maintenance services
      • 4.4.3.7.1. Product maintenance services estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.5. Contract Sales & Market Outsourcing
    • 4.5.1. Contract sales & market outsourcing market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.6. Others
    • 4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 5. Life Sciences BPO Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. Life Sciences BPO Market by Region: Key Takeaways
  • 5.3. North America
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.3.2. U.S.
      • 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.3.3. Canada
      • 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.4.2. Germany
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.4.3. France
      • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.4.4. Italy
      • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.4.5. Spain
      • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.4.6. Sweden
      • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.4.7. Norway
      • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.4.8. Denmark
      • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.5.2. China
      • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.5.3. India
      • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.5.4. Australia
      • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.5.5. Thailand
      • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.6.2. Mexico
      • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.6.3. Argentina
      • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 5.7. MEA
    • 5.7.1. Saudi Arabia
      • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.7.2. South Africa
      • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.7.3. UAE
      • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.7.4. Kuwait
      • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Market Participant Categorization
    • 6.2.1. Atos SE
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic Initiatives
    • 6.2.2. Boehringer Ingelheim International GmbH
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Catalent, Inc
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Labcorp Drug Development
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Genpact
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. ICON plc
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Infosys Limited
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. IBM
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Lonza
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives
    • 6.2.10. Parexel
      • 6.2.10.1. Company overview
      • 6.2.10.2. Financial performance
      • 6.2.10.3. Product benchmarking
      • 6.2.10.4. Strategic initiatives
    • 6.2.11. IQVIA Inc
      • 6.2.11.1. Company overview
      • 6.2.11.2. Financial performance
      • 6.2.11.3. Product benchmarking
      • 6.2.11.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 3 North America life sciences BPO market, by region, 2018 - 2030 (USD Billion)
  • Table 4 U.S. life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 5 Canada Life Sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 6 Europe life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 7 Europe life sciences BPO market, by region, 2018 - 2030 (USD Billion)
  • Table 8 Germany life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 9 UK life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 10 France life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 11 Italy life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 12 Spain life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 13 Sweden life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 14 Norway Life Sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 15 Denmark life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 16 Asia Pacific life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 17 Asia Pacific life sciences BPO market, by region, 2018 - 2030 (USD Billion)
  • Table 18 China Life Sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 19 Japan Life Sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 20 India life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 21 Australia life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 22 Thailand Life Sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 23 South Korea life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 24 Latin America life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 25 Latin America life sciences BPO market, by region, 2018 - 2030 (USD Billion)
  • Table 26 Brazil life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 27 Mexico Life Sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 28 Argentina life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 29 Middle East and Africa life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 30 Middle East and Africa life sciences BPO market, by region, 2018 - 2030 (USD Billion)
  • Table 31 South Africa life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 32 Saudi Arabia Life Sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 33 UAE life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 34 Kuwait Life Sciences BPO market, by services, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Microneedle drug delivery systems: Market outlook
  • Fig. 9 Microneedle drug delivery systems: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Life sciences BPO market driver impact
  • Fig. 15 Life sciences BPO market restraint impact
  • Fig. 16 Life sciences BPO market strategic initiatives analysis
  • Fig. 17 Life sciences BPO market: Services movement analysis
  • Fig. 18 Life sciences BPO market: Services outlook and key takeaways
  • Fig. 19 Pharmaceutical outsourcing market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 20 Contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 21 API market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 22 Finished dose form market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 23 Packaging market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 24 Contract research organizations market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 25 Drug discovery market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 26 Preclinical studies market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 27 Clinical trial studies market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 28 Regulatory services market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 29 Pharmacovigilance market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 30 Medical devices outsourcing market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 31 Contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 32 Electronic manufacturing services market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 33 Finished goods market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 34 Raw materials/components market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 35 Contract research organizations manufacturing market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 36 Regulatory consulting services market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 37 Product design and development services market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 38 Product testing services market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 39 Product implementation services market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 40 Product upgrade services market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 41 Product maintenance services market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 42 Contract sales & market outsourcing market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 43 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 44 Global life sciences BPO market: Regional movement analysis
  • Fig. 45 Global life sciences BPO market: Regional outlook and key takeaways
  • Fig. 46 North America market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 47 U.S. market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 48 Canada market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 49 Europe market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 50 UK market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 51 Germany market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 52 France market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 53 Italy market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 54 Spain market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 55 Sweden market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 56 Norway market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 57 Denmark market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 58 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 59 Japan market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 60 China market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 61 India market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 62 Australia market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 63 Thailand market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 64 South Korea market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 65 Latin America market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 66 Brazil market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 67 Mexico market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 68 Argentina market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 69 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 70 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 71 South Africa market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 72 UAE market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 73 Kuwait market estimates and forecasts, 2018 - 2030 (USD Billion)